Pulse Biosciences lists COO as SEC reporting insider

PULSE BIOSCIENCES, INC.

Rhea-AI Filing Summary

PULSE BIOSCIENCES, INC. (PLSE) filed an initial ownership report for Liane Rae Teplitsky, who serves as Chief Operating Officer. The Form 3 does not list any reportable holdings or transactions and includes a power of attorney as an exhibit authorizing certain filings on her behalf.

Key Terms

Form 3, Chief Operating Officer, Power of Attorney

3 terms

Form 3 regulatory

"filed an initial ownership report for Liane Rae Teplitsky"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

Chief Operating Officer financial

"serves as Chief Operating Officer"

A chief operating officer (COO) is a senior executive responsible for overseeing the day-to-day activities of a company, ensuring that all parts of the organization work smoothly and efficiently. They often act like a company's operational quarterback, translating strategic plans into practical actions. For investors, the COO's effectiveness can influence a company's performance and stability, making them an important figure in assessing the company's management strength.

Power of Attorney regulatory

"Exhibit 24 - Power of Attorney"

A power of attorney is a legal document that allows one person to make decisions and act on behalf of another person, often in financial or legal matters. It’s like giving someone a trusted helper or agent the authority to handle important tasks if you are unable to do so yourself. This matters to investors because it can impact how their assets are managed or transferred if they become unable to oversee their affairs.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Who is the new insider reported for PLSE on this Form 3?

The Form 3 identifies Liane Rae Teplitsky as a reporting person for PULSE BIOSCIENCES, INC. (PLSE), serving as Chief Operating Officer. The filing establishes her insider status for SEC reporting purposes but does not show any current reportable holdings or transactions.

Does this PLSE Form 3 show any stock transactions by Liane Rae Teplitsky?

No. The Form 3 shows no reported transactions, with buyCount, sellCount, acquireCount, and disposeCount all at zero. It functions as an initial statement of beneficial ownership without disclosing any trades.

Are any PLSE shares or derivatives reported as held by Liane Rae Teplitsky?

No. The filing’s transactionSummary shows holdingEntries: 0 and derivativeTransactionCount: 0, and there is no derivativeSummary detail, indicating no reportable equity or derivative positions are listed in this initial statement.

What exhibit is attached to this PLSE Form 3?

The remarks section lists an exhibit: Exhibit 24 – Power of Attorney. This typically authorizes designated individuals to sign and submit SEC ownership reports on behalf of Liane Rae Teplitsky.

Is there any Rule 10b5-1 trading plan noted in this PLSE Form 3?

No. The document-level Rule 10b5-1 indicator is null, and there are no transaction footnotes describing trades under a Rule 10b5-1 plan, consistent with the absence of any reported transactions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/28/2026 - 07:42 PM EDT Accepted by SEC EDGAR 08/28/2026 - 07:41 PM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Teplitsky Liane Rae

(Last) (First) (Middle)

C/O PULSE BIOSCIENCES, INC.

3957 POINT EDEN WAY

(Street)

HAYWARD CALIFORNIA 94545

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
04/08/2026

3. Issuer Name and Ticker or Trading Symbol
PULSE BIOSCIENCES, INC. [ PLSE ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Operating Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney

No securities are beneficially owned.

	/s/ Kenneth B. Stratton	08/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)